FAMETH-A™

FAMETH-A is a long-acting depot corticosteroid formulation of Methylprednisolone Acetate, developed to deliver sustained anti-inflammatory and immunosuppressive effects. Designed for parenteral use, it ensures gradual release of the active ingredient, allowing prolonged therapeutic action with reduced dosing frequency.This formulation is particularly beneficial in managing chronic, severe, and recurrent inflammatory conditions where continuous symptom control is essential. Its reliable pharmacological profile makes it a preferred choice in clinical settings requiring consistent and long-lasting corticosteroid therapy.

Mechanism of Action

Methylprednisolone Acetate exerts its action by modulating the body’s inflammatory and immune responses. It inhibits the migration of leukocytes to sites of inflammation and suppresses the release of pro-inflammatory mediators such as cytokines, prostaglandins, and leukotrienes.Additionally, it reduces capillary permeability, thereby minimizing edema, redness, and tissue swelling. The depot nature of the formulation allows slow and sustained release of the drug, ensuring prolonged suppression of inflammatory processes and stable symptom control over time.

Indications

FAMETH-A is indicated in a wide range of conditions where corticosteroid therapy is required, including:

• Severe allergic reactions and hypersensitivity disorders
• Rheumatoid arthritis and other inflammatory joint conditions
• Osteoarthritis (intra-articular use for symptomatic relief)
• Musculoskeletal inflammation such as bursitis and tendinitis
• Dermatological conditions including dermatitis and eczema
• Autoimmune disorders requiring immunosuppressive therapy
• Chronic inflammatory conditions needing long-acting steroid support

Key Benefits

• Sustained Action: Depot formulation ensures prolonged therapeutic effect with fewer injections
• Powerful Anti-inflammatory Effect: Rapidly reduces inflammation, swelling, and associated pain
• Reliable Symptom Control: Helps manage chronic and recurrent inflammatory conditions effectively
• Improved Patient Compliance: Reduced frequency of administration enhances convenience
• Versatile Clinical Use: Suitable for multiple routes including intra-articular, intramuscular, and soft tissue administration
• Consistent Performance: Delivers predictable and dependable clinical outcomes

Dosage and Administration

FAMETH-A should be administered strictly under the supervision of a qualified healthcare professional. The dosage, route, and frequency depend on the condition being treated, its severity, and patient response.It may be administered via intra-articular, intramuscular, or soft tissue injection as per clinical requirement. Proper aseptic precautions should be followed during administration. Dose adjustments may be necessary based on therapeutic response and clinical judgment.

Why Choose FAMETH-A?

FAMETH-A stands out as a dependable long-acting corticosteroid designed for modern clinical needs. Its depot formulation ensures extended relief, reducing the need for frequent dosing while maintaining consistent therapeutic levels.Backed by the proven efficacy of Methylprednisolone, it offers strong control over inflammation and immune-mediated conditions. Its versatility across multiple indications, combined with reliable quality standards, makes it a trusted choice for healthcare professionals seeking effective and sustained patient outcomes.